For more information or confidential assistance
800-306-3180
se habla español

Invokana Lawsuit Alleges Drug Caused Urosepsis

Severe side effects of Invokana – part of a new class of diabetes drugs manufactured by J&J – have prompted a wave of litigation filed throughout the United States. Most of the Invokana lawsuits have been centralized in New Jersey federal court under MDL # 2750 for more efficient pretrial... Read more »

Androgel Bellwether Trial Ruling Favors Plaintiffs

Premises liability lawyer Los Angeles
In a case management order filed by US District Judge Matthew F. Kennelly, Androgel maker AbbVie was denied its attempt to have the first bellwether case dismissed on grounds that the statute of limitations had expired. The testosterone lawsuit, filed by Jeffrey Konrad, was originally selected as a representative case... Read more »

Massive $110 Million Verdict for Talc Powder Plaintiff

Like many other women, Lois Slemp routinely used talcum powder for feminine hygiene purposes. The Virginia resident had used Johnson & Johnson’s talc powder for four decades, and then she was diagnosed with ovarian cancer. Her cancer was initially discovered in 2012. After going into remission, she suffered a recurrence... Read more »

Federal Farxiga Lawsuits Consolidated in NY

The makers of Farxiga, Bristol-Myers Squibb and AstraZeneca, are facing at least 18 product liability lawsuits filed in federal courts. These have now been centralized into a multidistrict litigation (MDL) pursuant to an order issued by the U.S. Judicial Panel on Multidistrict Litigation (JPML) issued on April 6, 2017. The... Read more »

First Steps Commence in Invokana Litigation

Antidepressant Lawsuit
In mid-January, the first steps in the Invokana multidistrict litigation (MDL) began. U.S. District Judge Brian Martinotti, who is presiding over the MDL in the District of New Jersey, announced 1) the pending appointment of a special mediator to deal with discovery issues and settlement possibilities and 2) a “science... Read more »